Home

Akebia Therapeutics, Inc. - Common Stock (AKBA)

2.2600
+0.5700 (33.73%)

Akebia Therapeutics is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with kidney disease

The company is primarily engaged in addressing unmet medical needs in anemia caused by chronic kidney disease, aiming to enhance patient outcomes through its proprietary treatments and drug candidates. Akebia's research and development efforts are centered around creating therapies that improve the management of renal diseases by promoting better health and quality of life for patients suffering from kidney-related conditions.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close1.690
Open1.770
Bid2.210
Ask2.240
Day's Range1.755 - 2.290
52 Week Range0.8000 - 2.480
Volume13,249,878
Market Cap394.45M
PE Ratio (TTM)-6.647
EPS (TTM)-0.3
Dividend & YieldN/A (N/A)
1 Month Average Volume3,120,891

News & Press Releases

Top movers analysis one hour before the close of the markets on 2025-03-14: top gainers and losers in today's session.chartmill.com
Stay up-to-date with the latest market trends one hour before the close of the markets on Friday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · March 14, 2025
Which stocks are experiencing notable movement on Friday?chartmill.com
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · March 14, 2025
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · March 14, 2025
Recap: Akebia Therapeutics Q4 Earningsbenzinga.com
Via Benzinga · March 14, 2024
Earnings Preview For Akebia Therapeuticsbenzinga.com
Via Benzinga · March 13, 2024
Earnings Outlook For Akebia Therapeuticsbenzinga.com
Via Benzinga · November 7, 2023
Semtech Posts Better-Than-Expected Earnings, Joins Rubrik, DocuSign, PagerDuty And Other Big Stocks Moving Higher On Fridaybenzinga.com
Via Benzinga · March 14, 2025
Earnings Scheduled For March 13, 2025benzinga.com
Via Benzinga · March 13, 2025
AKBA Stock Earnings: Akebia Therapeutics Misses EPS, Misses Revenue for Q1 2024investorplace.com
AKBA stock results show that Akebia Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 9, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · April 10, 2024
Akebia Therapeutics Surges on FDA Approval for Anemia Treatment
Akebia Therapeutics Inc. (NASDAQAKBA) is a biopharmaceutical company specializing in developing treatments for chronic kidney diseases (CKD) and anemia
Via MarketBeat · April 3, 2024
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · March 29, 2024
10 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · March 28, 2024
FDA Approves For Akebia Therapeutics' Vafseo For Kidney Disease Associated Anemiabenzinga.com
The FDA-approved Vafseo tablets by Akebia Therapeutics for managing anemia in adult dialysis patients with chronic kidney disease. Learn about its once-daily oral HIF-PH inhibitor and global approval in 37 countries.
Via Benzinga · March 28, 2024
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarketbenzinga.com
Shares of RH (NYSERH) rose sharply in today’s pre-market trading following the release of quarterly results.
Via Benzinga · March 28, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · March 28, 2024
Akebia Therapeutics Inc. (NASDAQ: AKBA) is One of Thursday Morning’s Most Active Stocks
Akebia Therapeutics, Inc. (NASDAQAKBA) is one today’s most active stocks by volume. So far today, approximately 31.95M shares of Akebia Therapeutics, Inc. have been exchanged, as compared to an average 30-day volume of 4.98M shares.
Via Investor Brand Network · March 28, 2024
Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesdaybenzinga.com
U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.
Via Benzinga · March 27, 2024
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · March 15, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · March 15, 2024
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Sessionbenzinga.com
Shares of Westport Fuel Systems Inc. (NASDAQWPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.
Via Benzinga · March 26, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Fridayinvestorplace.com
It's time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning!
Via InvestorPlace · March 15, 2024
AKBA Stock Earnings: Akebia Therapeutics Beats Revenue for Q4 2023investorplace.com
AKBA stock results show that Akebia Therapeutics beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 14, 2024
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · March 14, 2024
Earnings Scheduled For March 14, 2024benzinga.com
Companies Reporting Before The Bell • Pharming (NASDAQPHAR) is projected to report earnings for its fourth quarter.
Via Benzinga · March 14, 2024